Indidataroxyl bromide inhalation powder human bioequivalence study (chinadrugtrials.org.cn) - Oct 20, 2026 - P=N/A | N=50 | Not yet recruiting | Sponsor: Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd.
New trial • Bronchiectasis • Chronic Obstructive Pulmonary Disease • Immunology • Pulmonary Disease • Respiratory Diseases
|